Dartmouth researchers have developed a fluorescence imaging technique that can more accurately identify receptors for targeted cancer therapies without a tissue biopsy.
Articles by: Robin Dutcher
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine.
As students across the region prepare for their fall athletic season, Dartmouth researchers are reporting that these activities can bring more health benefits than cardiovascular health and obesity prevention.
“Virtual Prouty-ers” have walked the Great Wall of China, run in Australia, cycled in France, and mountain biked in California.
Dartmouth researchers have found that early exposure to the ultraviolet radiation lamps used for indoor tanning is related to an increased risk of developing basal cell carcinomas (BCC) at a young age.
A Dartmouth researcher has found that reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor 1 (IGF1) receptor.
In a recent study, offering support services soon after a patient’s diagnosis reduced depression among caregivers.
New research by an international group of scientists confirms a vulnerability to lung cancer can be inherited and implicates the BRCA2 gene as harboring one of the involved genetic mutations.
James D. Gorham, MD, PhD, an associate professor of pathology and of microbiology and immunology, has been named the first associate director for education at Dartmouth-Hitchcock Norris Cotton Cancer Center.
Using next generation DNA sequencing, Dartmouth scientists have identified potentially actionable mutations in cancers of the appendix. When specific mutations for a cancer type are identified, patients can be treated with chemotherapy or other targeted agents that work on those mutations.